Vontobel Holding Ltd. Abiomed Inc Transaction History

Vontobel Holding Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$242.49 - $301.46 $84,144 - $104,606	347 Added 10.47%	3,662 $899,000
Q2 2022 Jul 27, 2022	BUY	$224.73 - $338.64 $253,270 - $381,647	1,127 Added 51.51%	3,315 $850,000
Q1 2022 May 13, 2022	SELL	$277.25 - $366.29 $10,812 - $14,285	-39 Reduced 1.75%	2,188 $719,000
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $335,202 - $414,055	1,115 Added 100.27%	2,227 $807,000
Q3 2021 Oct 29, 2021	SELL	$310.19 - $376.2 $11,787 - $14,295	-38 Reduced 3.3%	1,112 $362,000
Q2 2021 Aug 06, 2021	BUY	$262.71 - $351.17 $16,288 - $21,772	62 Added 5.7%	1,150 $360,000
Q1 2021 May 11, 2021	SELL	$285.92 - $355.13 $43,173 - $53,624	-151 Reduced 12.19%	1,088 $347,000
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $312,079 - $401,683	1,239 New	1,239 $404,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.